1.32
Precedente Chiudi:
$1.79
Aprire:
$1.38
Volume 24 ore:
2.55M
Relative Volume:
3.26
Capitalizzazione di mercato:
$93.36M
Reddito:
$299.48M
Utile/perdita netta:
$-86.45M
Rapporto P/E:
-0.88
EPS:
-1.5
Flusso di cassa netto:
$-17.32M
1 W Prestazione:
-32.31%
1M Prestazione:
-28.26%
6M Prestazione:
-57.83%
1 anno Prestazione:
-67.88%
Health Catalyst Inc Stock (HCAT) Company Profile
Nome
Health Catalyst Inc
Settore
Industria
Telefono
801-708-6800
Indirizzo
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, TEM, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
HCAT
Health Catalyst Inc
|
1.32 | 93.36M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
178.88 | 29.40B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
49.98 | 8.94B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
38.31 | 7.36B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
77.81 | 6.65B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.16 | 4.63B | 1.10B | 112.09M | 283.19M | 0.6096 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-27 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Downgrade | Citigroup | Buy → Neutral |
| 2025-08-08 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2024-01-03 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Iniziato | Stephens | Equal-Weight |
| 2023-04-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Iniziato | Wells Fargo | Equal Weight |
| 2022-10-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Downgrade | Stifel | Buy → Hold |
| 2022-04-14 | Iniziato | Guggenheim | Buy |
| 2022-03-17 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-02 | Iniziato | Jefferies | Hold |
| 2021-10-14 | Iniziato | BTIG Research | Buy |
| 2021-04-29 | Ripresa | JP Morgan | Overweight |
| 2020-12-08 | Iniziato | Berenberg | Buy |
| 2020-07-14 | Iniziato | Citigroup | Buy |
| 2020-06-18 | Iniziato | Stifel | Buy |
| 2020-06-15 | Ripresa | Evercore ISI | Outperform |
| 2020-05-15 | Iniziato | Guggenheim | Buy |
| 2020-04-21 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-04-13 | Iniziato | SVB Leerink | Outperform |
| 2020-04-02 | Iniziato | Canaccord Genuity | Buy |
| 2019-12-20 | Iniziato | Raymond James | Strong Buy |
| 2019-10-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Iniziato | Evercore ISI | Outperform |
| 2019-08-19 | Iniziato | Goldman | Buy |
| 2019-08-19 | Iniziato | JP Morgan | Overweight |
| 2019-08-19 | Iniziato | Piper Jaffray | Overweight |
| 2019-08-19 | Iniziato | SVB Leerink | Outperform |
| 2019-08-19 | Iniziato | SunTrust | Buy |
| 2019-08-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Health Catalyst Inc Borsa (HCAT) Ultime notizie
Health Catalyst (HCAT) Losses Swell To US$178 Million Challenging Margin Improvement Narrative - simplywall.st
HCAT Rating Maintained as Citigroup Lowers Price Target | HCAT S - GuruFocus
Citigroup Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $1.75 - MarketBeat
Health Catalyst (HCAT) Shares Plummet After Mixed Q4 Results - GuruFocus
Health Catalyst (HCAT) Receives Analyst Rating Update from Steph - GuruFocus
HCAT: Canaccord Genuity Lowers Price Target But Maintains Buy Ra - GuruFocus
Health Catalyst (NASDAQ:HCAT) Given New $2.00 Price Target at Stephens - MarketBeat
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Health Catalyst plummets after mixed Q4; CEO declines to rule out potential sale as part of review - Seeking Alpha
Stifel Nicolaus Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $2.00 - MarketBeat
Canaccord cuts Health Catalyst stock price target on weak guidance - Investing.com Nigeria
Canaccord cuts Health Catalyst stock price target on weak guidance By Investing.com - Investing.com India
Stifel cuts Health Catalyst stock price target on migration woes - Investing.com Nigeria
Cantor Fitzgerald cuts Health Catalyst stock price target on turnaround uncertainty - Investing.com
Stifel cuts Health Catalyst stock price target on migration woes By Investing.com - Investing.com Australia
Earnings call transcript: Health Catalyst Q4 2025 results show mixed performance - Investing.com Nigeria
Health Catalyst refrains from 2026 annual guidance as new CEO launches operational overhaul and strategic review - MSN
Health Catalyst Inc (HCAT) Q4 2025 Earnings Call Highlights: Navigating Revenue Challenges and ... By GuruFocus - Investing.com Canada
Earnings Call Summary | Health Catalyst(HCAT.US) Q4 2025 Earnings Conference - 富途牛牛
Health Catalyst (HCAT) Reports $311.1M Revenue for 2025, New Lea - GuruFocus
Health Catalyst Q4 Earnings Call Highlights - Yahoo Finance
Health Catalyst, Inc. 2025 Annual Report: Data-Driven Healthcare Improvement, Company Mission, and Growth Strategies - Minichart
Health Catalyst (HCAT) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance UK
Health Catalyst Q4 2025 Financial Report: Revenue $74.7M, Loss $91MNews and Statistics - IndexBox
Health Catalyst Q4 2025 Earnings: Revenue Beat, Lower Guidance for 2026News and Statistics - IndexBox
Health Catalyst (HCAT) Lags Q4 Earnings Estimates - Yahoo Finance
Health Catalyst (HCAT) Reports Strong Q4 Revenue and Outlines Fu - GuruFocus
Health Catalyst: Fourth Quarter Earnings Overview - Bitget
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Health Catalyst (NASDAQ: HCAT) outlines healthcare data analytics strategy - Stock Titan
Health Catalyst: Q4 Earnings Snapshot - king5.com
Health Catalyst (NASDAQ:HCAT) Posts Better-Than-Expected Sales In Q4 CY2025 But Stock Drops 10.4% - Yahoo Finance
Health Catalyst Inc (HCAT) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Health Catalyst (NASDAQ:HCAT) Announces Quarterly Earnings Results - MarketBeat
Health Catalyst Reports Fourth Quarter and Year End 2025 Results - The Manila Times
Health Catalyst, Inc. Provides Earnings Guidance for the First Quarter of 2026 - marketscreener.com
Health Catalyst (HCAT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - finance.yahoo.com
HCAT Projects Q1 Adjusted EBITDA of $7M-$8M Amid CEO Transition - GuruFocus
How The Health Catalyst (HCAT) Story Is Shifting After A Tough 2025 For Health Tech - Yahoo Finance
Health Catalyst (HCAT) Q4 Earnings: What To Expect - Yahoo Finance UK
Health Catalyst (NASDAQ: HCAT) insider sells 18,270 restricted shares reported - Stock Titan
Gear Up for Health Catalyst (HCAT) Q4 Earnings: Wall Street Estimates for Key Metrics - Yahoo Finance
Big Picture: Is Health Catalyst Inc. a top pick in the sectorTrade Signal Summary & Technical Confirmation Trade Alerts - baoquankhu1.vn
Aug Weekly: Does Health Catalyst Inc have a sustainable dividend2025 EndofYear Setup & Short-Term High Return Strategies - baoquankhu1.vn
Health Catalyst urges HIMSS26 attendees to prioritize performance metrics with expert strategy sessions - Traders Union
3 Stocks Under $10 We're Skeptical Of - Finviz
Health Catalyst, AppLovin, PubMatic, and Pegasystems Stocks Trade Up, What You Need To Know - The Globe and Mail
Health Catalyst, AppLovin, PubMatic, and Pegasystems Shares Rise, Key Information to Consider - Bitget
Bentley Systems, Guidewire Software, Health Catalyst, and Doximity Shares Skyrocket, What You Need To Know - The Globe and Mail
26,970 restricted HCAT shares to be sold (HCAT) via Morgan Stanley - Stock Titan
Health Catalyst to Announce Fourth Quarter and Year End 2025 Operating Results and Host Conference Call on Thursday, March 12, 2026 - Bitget
Health Catalyst Inc Azioni (HCAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):